SCHEMBL25645656

SCHEMBL25645656

c1ccc(-c2nc(-c3ccc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)cc3)nc(-c3ccc4c(c3)oc3ccccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.36
SLC9A1 P19634 2/20 0.35
HCRTR1 O43613 1/20 0.35
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
PRKDC P78527 2/20 0.34
BRDT Q58F21 1/20 0.34
AHR P35869 1/20 0.34
LIMK1 P53667 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.33
ALOX5 P09917 1/20 0.33
POLB P06746 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645611 1.00 F9 (0.36) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL23913450 0.99 HCRTR1 (0.37) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL25646009 0.99 F9 (0.36) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL25645660 0.98 HCRTR1 (0.36) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL25645850 0.97 HCRTR1 (0.34) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL25645642 0.97 PRKDC (0.36) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL23913442 0.97 F9 (0.35) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL23913427 0.96 PLA2G2A (0.36) F9SLC9A1HCRTR1MMP12MMP13
SCHEMBL25645671 0.96 HCRTR1 (0.36) F9HCRTR1MMP12MMP13PRKDC
SCHEMBL25645895 0.96 F9 (0.34) F9SLC9A1HCRTR1MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 F9 785/4885SLC9A1 3536/4885HCRTR1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.